Transparency Market Research (TMR) has released a new market study on the global tuberculosis testing market, titled “Tuberculosis Testing Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020”. The TMR report projects the global market for tuberculosis testing to expand at a modest 4.3% CAGR from 2014 to 2020, for the market to have a valuation of US$2.6 bn by 2020, increasing from its 2013 valuation of US$1.9 bn.
According to a report from the World Health Organization (WHO), tuberculosis has been identified as the second deadliest disease in the world after HIV/AIDS. Tuberculosis was the cause of 1.5 mn deaths across the globe in 2013, adds the WHO report.As such, the prevalence of the disease in alarming numbers has led to the increased use of TB testing techniques. In order to curb the prevalence of the disease, government and non-government bodies are taking initiatives to promote awareness about TB and have introduced control programs, leading to increased demand for TB testing.
Download Complete Healthcare Analytical Brochure:
Latent tuberculosis and active tuberculosis are the most prevalent forms of TB. Over time, Mycobacterium tuberculosis, the TB-causing pathogen, has developed into drug-resistant strains of tuberculosis that are either multi-drug-resistant (MDR) or extensively drug-resistant (XDR). Thus, the growing demand for advanced TB testing techniques and equipment will propel the market. However, high cost of TB testing is cited as a challenge to the growth of the TB testing market.The report divides the global market for tuberculosis testing on the basis of test type and geography. By test type, smear microscopy, nucleic acid testing, radiography, culture-based tests, drug susceptibility testing, Mantoux test, and others (IGRA, serological tests, ADA, etc.) are the prime segments of the global market for tuberculosis testing.
In 2013, culture-based TB tests held the largest market share and accounted for US$691.2 mn in the overall market for tuberculosis testing. The culture-based TB tests segment is expected to display consistent growth during the forecast period due to the reliability and accuracy of these tests.By geography, North America, Asia Pacific, Europe, and Rest of the World (RoW) are the segments of the global market for TB testing. In 2013, Asia Pacific emerged as the largest market for TB testing. The prevalence of a large TB patient pool due to unregulated emissions from industries and high air pollution in developing countries such as India and Malaysia accounted for Asia Pacific’s 35% share in the overall market.
Global strategic Business report :
North America stands as the second largest market for TB testing and is closely trailed by Europe. Spain, France, Germany, and Italy are the major markets for TB testing in Europe.The report identifies key players operating in the global market for TB testing, namely Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Akonni Biosystems Inc., Alere Inc. Hain Lifescience GmbH, Abbott Laboratories, Becton, Dickinson and Company, Hologic Inc., and QIAGEN.
The global tuberculosis testing market is segmented as follows:
Tuberculosis Testing Market, by Test Type
- Smear Microscopy
- Culture Based Tests
- Nucleic Acid Testing
- Mantoux Test (Tuberculin Skin Test)
- Radiography (Chest X-Ray)
- Drug Susceptibility Testing (DST)
- Other Tests (Serological Tests, IGRA, ADA, etc.)
Tuberculosis Testing Market, by Geography
- North America
- Rest of the World (RoW)